title: [Role of coronary risk factors in blood thrombogenicity and acute coronary syndromes].
abstract: Recent advances in basic science have linked some systemic risk factors to endothelial dysfunction which gives rise to atherosclerotic disease and triggers the progression of thrombotic complications. Superficial erosion of the stenotic plaque can be observed in one-third of acute coronary syndromes (ACS). In these cases the presence of classic risk factors such as diabetes mellitus, hypercholesterolemia and smoking favor a state of "vulnerable blood" or high risk. Increased thrombogenicity can exacerbate thrombus formation and is able to trigger an ACS. The vessel endothelium regulates contractile, mitogenic and thrombotic activities of the vessel wall. Risk factors impair both homeostasis and hemostasis of the vessel wall and promote inflammatory signals. Platelet and monocyte activation favors the expression of tissue factor (TF), thus triggering the coagulation cascade with thrombin generation and clot formation. Increased blood thrombogenicity linked to classic risk factors may be associated with circulating TF levels which are much higher than those observed in healthy subjects without risk factors. These observations not only emphasize the usefulness of aggressive management of risk factors but open a new avenue for future studies to devise therapeutic strategies to treat ACS by inhibiting TF expression.
authors.affiliation: Servicio de Cardiología, Hospital de Terrassa, Barcelona, España. asambola@yahoo.com
authors.forename: Antonia
authors.initials: A
authors.lastname: Sambola
authors.forename: Valentín
authors.initials: V
authors.lastname: Fuster
authors.forename: Juan José
authors.initials: JJ
authors.lastname: Badimon
mesh_terms: D000208:Acute Disease; D003324:Coronary Artery Disease / Q000209:etiology*; D003328:Coronary Thrombosis / Q000209:etiology*; D048909:Diabetes Complications; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D013577:Syndrome; D013925:Thromboplastin / Q000502:physiology
chemical_list: D013925:Thromboplastin